Sage Therapeutics Inc (SAGE)

5.10 -0.27 (-5.03%) USD  |  NASDAQ  |  Nov 15, 16:00
5.105 0.00 (0.00%) After-Hours: 20:00
More

Sage Therapeutics Research and Development Expense (TTM): 253.20M for Sept. 30, 2024

Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2013. Upgrade now.
Date Value
September 30, 2024 253.20M
June 30, 2024 300.55M
March 31, 2024 335.14M
December 31, 2023 356.24M
September 30, 2023 381.20M
June 30, 2023 360.84M
March 31, 2023 340.97M
December 31, 2022 326.16M
September 30, 2022 312.31M
June 30, 2022 314.26M
March 31, 2022 303.13M
December 31, 2021 283.17M
September 30, 2021 289.43M
June 30, 2021 280.01M
March 31, 2021 287.16M
December 31, 2020 292.71M
September 30, 2020 302.26M
June 30, 2020 330.29M
March 31, 2020 346.03M
December 31, 2019 368.82M
September 30, 2019 366.37M
June 30, 2019 339.31M
Date Value
March 31, 2019 319.24M
December 31, 2018 282.11M
September 30, 2018 244.19M
June 30, 2018 227.43M
March 31, 2018 214.35M
December 31, 2017 210.28M
September 30, 2017 201.39M
June 30, 2017 172.18M
March 31, 2017 142.38M
December 31, 2016 120.76M
September 30, 2016 99.13M
June 30, 2016 87.53M
March 31, 2016 80.04M
December 31, 2015 69.36M
September 30, 2015 57.93M
June 30, 2015 47.05M
March 31, 2015 32.83M
December 31, 2014 24.10M
September 30, 2014 19.67M
June 30, 2014 16.47M
March 31, 2014 15.95M
December 31, 2013 14.36M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

253.20M
Minimum
Sep 2024
381.20M
Maximum
Sep 2023
318.19M
Average
313.28M
Median

Research and Development Expense (TTM) Benchmarks

Outset Medical Inc 43.04M
Biogen Inc 2.080B
Johnson & Johnson 16.41B
Lifecore Biomedical Inc 8.615M
Organon & Co 473.00M